Suppr超能文献

DFL23448,一种新型的瞬时受体电位香草酸亚型8选择性离子通道拮抗剂,可改变膀胱功能并减轻清醒大鼠的膀胱过度活动。

DFL23448, A Novel Transient Receptor Potential Melastin 8-Selective Ion Channel Antagonist, Modifies Bladder Function and Reduces Bladder Overactivity in Awake Rats.

作者信息

Mistretta Francesco A, Russo Andrea, Castiglione Fabio, Bettiga Arianna, Colciago Giorgia, Montorsi Francesco, Brandolini Laura, Aramini Andrea, Bianchini Gianluca, Allegretti Marcello, Bovolenta Silvia, Russo Roberto, Benigni Fabio, Hedlund Petter

机构信息

Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy (F.A.M., A.R., F.C., A.B., G.C., F.M., F.B., P.H.); Department of Clinical and Experimental Pharmacology, Lund University, Lund, Sweden (F.A.M., P.H.); Università Vita-Salute San Raffaele, Milan, Italy (F.M.); Discovery Department, Research Centre Dompé Farmaceutici SpA, L'Aquila, Italy (L.B., A.A., G.B., M.A.); Discovery Biology, Axxam, Bresso, Milan, Italy (S.B.); Department of Pharmacy, Federico II University of Naples, Naples, Italy (R.R.); and Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Sweden (P.H.).

Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy (F.A.M., A.R., F.C., A.B., G.C., F.M., F.B., P.H.); Department of Clinical and Experimental Pharmacology, Lund University, Lund, Sweden (F.A.M., P.H.); Università Vita-Salute San Raffaele, Milan, Italy (F.M.); Discovery Department, Research Centre Dompé Farmaceutici SpA, L'Aquila, Italy (L.B., A.A., G.B., M.A.); Discovery Biology, Axxam, Bresso, Milan, Italy (S.B.); Department of Pharmacy, Federico II University of Naples, Naples, Italy (R.R.); and Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Sweden (P.H.)

出版信息

J Pharmacol Exp Ther. 2016 Jan;356(1):200-11. doi: 10.1124/jpet.115.228684. Epub 2015 Nov 6.

Abstract

The transient receptor potential melastin 8 ion channel (TRPM8) is implicated in bladder sensing but limited information on TRPM8 antagonists in bladder overactivity is available. This study characterizes a new TRPM8-selective antagonist (DFL23448 [5-(2-ethyl-2H-tetrazol-5-yl)-2-(3-fluorophenyl)-1,3-thiazol-4-ol]) and evaluates it in cold-induced behavioral tests and tests on bladder function and experimental bladder overactivity in vivo in rats. DFL23448 displayed IC50 values of 10 and 21 nM in hTRPM8 human embryonic kidney 293 cells activated by Cooling Agent 10 or cold, but it had limited activity (IC50 > 10 μM) at transient receptor potential vanilloids TRPV1, TRPA1, or TRPV4 or at various G protein-coupled receptors. In rats, DFL23448 administered intravenously or orally had a half-life of 37 minutes or 4.9 hours, respectively. DLF23448 (10 mg/kg i.v.) reduced icilin-induced "wet dog-like" shakes in rats. Intravesical DFL23448 (10 mg/l), but not vehicle, increased micturition intervals, micturition volume, and bladder capacity. During bladder overactivity by intravesical prostaglandin E2 (PGE2), vehicle controls exhibited reductions in micturition intervals, micturition volumes, and bladder capacity by 37%-39%, whereas the same parameters only decreased by 12%-15% (P < 0.05-0.01 versus vehicle) in DFL23448-treated rats. In vehicle-treated rats, but not in DFL23448-treated rats, intravesical PGE2 increased bladder pressures. Intravenous DFL23448 at 10 mg/kg, but not 1 mg/kg DFL23448 or vehicle, increased micturition intervals, micturition volumes, and bladder capacity. During bladder overactivity by intravesical PGE2, micturition intervals, micturition volumes, and bladder capacity decreased in vehicle- and 1 mg/kg DFL23448-treated rats, but not in 10 mg/kg DFL23448-treated rats. Bladder pressures increased less in rats treated with DFL23448 10 mg/kg than in vehicle- or 1 mg/kg DFL23448-treated rats. DFL23448 (10 mg/kg i.v.), but not vehicle, prevented cold stress-induced bladder overactivity. Our results support a role for bladder TRPM8-mediated signals in experimental bladder overactivity.

摘要

瞬时受体电位褪黑素8离子通道(TRPM8)与膀胱感觉功能有关,但关于TRPM8拮抗剂在膀胱过度活动症方面的信息有限。本研究对一种新型TRPM8选择性拮抗剂(DFL23448 [5-(2-乙基-2H-四唑-5-基)-2-(3-氟苯基)-1,3-噻唑-4-醇])进行了特性分析,并在冷诱导行为试验以及大鼠体内膀胱功能和实验性膀胱过度活动症试验中对其进行了评估。DFL23448在由冷却剂10或寒冷激活的人TRPM8人胚肾293细胞中显示出10和21 nM的半数抑制浓度(IC50)值,但它在瞬时受体电位香草酸类受体TRPV1、TRPA1或TRPV4或各种G蛋白偶联受体处活性有限(IC50>10 μM)。在大鼠中,静脉注射或口服DFL23448的半衰期分别为37分钟或4.9小时。DFL23448(10 mg/kg静脉注射)减少了大鼠中冰莲蛋白诱导的“湿狗样”抖动。膀胱内注射DFL23448(10 mg/l)而非赋形剂,增加了排尿间隔、排尿量和膀胱容量。在膀胱内注射前列腺素E2(PGE2)引起膀胱过度活动期间,赋形剂对照组的排尿间隔、排尿量和膀胱容量降低了37%-39%,而在DFL23448处理的大鼠中,相同参数仅降低了12%-15%(与赋形剂相比,P<0.05-0.01)。在赋形剂处理的大鼠中,而非DFL23448处理的大鼠中,膀胱内注射PGE2增加了膀胱压力。静脉注射10 mg/kg的DFL23448而非1 mg/kg的DFL23448或赋形剂,增加了排尿间隔、排尿量和膀胱容量。在膀胱内注射PGE2引起膀胱过度活动期间,赋形剂和1 mg/kg DFL23448处理的大鼠的排尿间隔、排尿量和膀胱容量降低,但10 mg/kg DFL23448处理的大鼠未降低。与赋形剂或1 mg/kg DFL23448处理的大鼠相比,10 mg/kg DFL23448处理的大鼠的膀胱压力升高幅度较小。DFL23448(10 mg/kg静脉注射)而非赋形剂,预防了冷应激诱导的膀胱过度活动。我们的结果支持膀胱TRPM8介导的信号在实验性膀胱过度活动症中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验